CEACAM5 and neoplasm: Patients classified with TNM above stage IIB, elevated preoperative carcinoembryonic antigen (CEA), angio-invasive growth, tumor perforation or obstruction and insufficient lymph node sampling (< 10 nodes) are eligible for adjuvant therapy6.